Participated · Convertible Note · Jun 2022

Trusty.care is a New York-based insurtech that provides an AI-driven 360 sales enablement solution for the individual health insurance and Medicare distribution market. Its products are used by insurance sales professionals to streamline quoting, enrollment, commissions, contracting, and licensing workflows. For carriers and FMOs the platform aims to improve retention, reduce spend on manual processes, and improve NPS. Trusty.care’s distribution model reaches consumers through partnerships, brokers, and carriers; contracted brokers grew from 1,000 to 50,000 in the last 18 months and the company works with 300+ health plan customers. The company plans to use new capital to grow the team, forge partnerships, ramp marketing, launch a Medicare Advantage retention product, and expand digital enrollment to 200+ health plans. The round brings Trusty.care’s total funding to $13M. Trusty.care operates a dual-facing digital platform that helps health insurance brokers and financial advisors identify financial risks older clients may face from healthcare costs. The platform matches customers with insurance products, public benefits, and cost-saving tools and includes both a consumer-facing marketplace and a broker-facing SaaS. The company sells its product on a per-broker SaaS basis and takes a share of transaction fees on the marketplace. Trusty.care's founders were inspired by hands-on eldercare experience and personal family healthcare events; CEO and cofounder Joseph Schneier discussed this background. The team is building data science behind a COVID-19 application that state governments are using to manage older adult residents, and they are using that data to inform their insurance business. The company has moved from pre-revenue to converting customers to paying and plans to reach 15,000 brokers and at least $100K MRR in the next six months. To date Trusty.care has raised $4.3M in total capital across multiple rounds. Trusty.care is a New York-based healthcare technology startup that provides a senior-focused, data-driven platform for Medicare beneficiaries. The platform uses predictive analytics to help reduce healthcare costs for seniors. It soft-launched on Oct. 15, 2018, providing data on 100 Medicare-covered medications. The platform has been authorized by CMS for integration with beneficiary claims data via Blue Button 2.0. The company raised $800k in pre-seed funding and intends to use the proceeds to expand operations and its business reach. Trusty.care is led by CEO Joseph Schneier.

Participated · Series A · Oct 2021

Optina develops a Retinal Deep PhenotypingTM platform that combines retinal imaging and AI to produce rapid, non-invasive diagnostic tests (a 1‑second eye scan) for brain health and systemic disease. Its lead product is the awAIrTM cerebral amyloid status test for Alzheimer's disease detection, and the company aims to support regulatory approval and clinical deployment of that test. Optina's platform received FDA Breakthrough Device Designation in 2019 for its first indication and its Optina-4CTM hyperspectral camera obtained 501(k) clearance in 2020. The company is running a pivotal clinical study across five sites in the USA, Canada and Europe and intends to expand cohort size and install its platform at additional leading institutions. Recent financing activity follows an oversubscribed Series A led by DigitalDx Ventures with participation from Boehringer Ingelheim Venture Fund, Desjardins, Zoic Capital and others. The new funding is intended to support the pivotal study and the FDA regulatory submission for the awAIr test and to accelerate broader clinical site deployment. Optina Diagnostics develops retinal imaging tools aimed at improving brain health and systemic disease detection, centered on its Retinal Deep PhenotypingTM platform. The company has an awAIrTM cerebral amyloid status test and the platform obtained FDA Breakthrough Device Designation in 2019 for a non-invasive test to aid Alzheimer’s disease evaluation. Optina is led by CEO David Lapointe. It closed a CA$24.8M Series A to support a pivotal study for the awAIr test and to advance platform development for early detection of systemic diseases. The financing will also accelerate deployment of additional clinical study sites and installations of its Retinal Deep PhenotypingTM platform at leading institutions in the United States, Canada and Europe. Optina Diagnostics is a Montreal-based company that uses artificial intelligence and spectral/hyperspectral retinal imaging to detect disease early, with an initial focus on Alzheimer’s. The company is developing a cerebral Amyloid prediction test based on retinal imaging and clinical data. Clinical data were gathered with financial support from CQDM and CTS, and the company says it is ready to extend its clinical sites. Leadership is headed by CEO David Lapointe. Optina intends to use newly raised funds to scale clinical development, accelerate regulatory approval efforts, and speed market readiness. The company raised C$4m in funding to support these plans.

Participated · Seed · May 2021

OpenUnit builds the online front-end and payment-processing infrastructure for independent self-storage facilities, taking a cut of payments rather than charging monthly subscriptions to owners. The product includes website storefronts, payment processing, and backend management tools designed to replicate in-person customer experiences online. The company acquired the IP of YC batchmate Affiga to add automated customer insights after transactions. OpenUnit has expanded into locations across the U.S. and Canada and reports a waitlist of over 800 facilities. The team has grown from the two co-founders to five employees and is continuing to hire. Future plans include converting the waitlist into customers and potentially offering loans to facilities using OpenUnit’s data to underwrite and guide renovations or expansions. OpenUnit builds management software and payments solutions for self-storage facilities. The company provides facilities with tools to manage transactions, connect teams, and power customer experience. Its revenue primarily comes from payment processing fees via OpenUnit Payments, a fully integrated merchant solution that accepts credit cards at competitive rates and includes a mobile point-of-sale for in-person payments. With $150K in pre-seed capital from Y Combinator, OpenUnit plans to launch its management software and payments offerings. It also intends to expand services directly through a marketplace that lists self-storage units. OpenUnit is co-founded by Taylor Cooney and Lucas Playford and participated in Y Combinator's Winter 2020 batch, receiving mentorship in California.

Participated · Seed · Jul 2020

Buzz Solutions offers PowerAI, a platform that transforms inspection imagery into actionable asset intelligence across transmission, distribution, substations and utility-scale solar. The company helps utilities modernize the electric grid by enabling improved reliability, reduced infrastructure risk and optimized maintenance at scale. Leadership includes co-founders and executives Kaitlyn Albertoli (CEO) and Vikhyat Chaudhry (CTO). Buzz Solutions works with utilities across North America, including Dominion Energy, American Electric Power and the New York Power Authority. The company is based in Palo Alto, CA. It plans to use the newly raised Series A funds to accelerate product innovation, expand go-to-market capabilities and deepen customer deployments.

Participated · Equity · Apr 2020

Wellpay offers a financial-technology platform powered by machine learning that enables patients to securely pay medical bills and upload bills they wish to pay over time. The platform negotiates with providers, facilitates disputes, or provides zero-interest, zero-fees payment plans, and handles payment plans, bill management, and communication via the platform. For medical providers—including urgent care centers, dentists, primary care physicians, OB-GYNs, psychiatrists, chiropractors and more—Wellpay aims to eliminate the burden of patient payment efforts. The company is led by CEO and co-founder Mohammad Gaber. Wellpay raised $3.8M in funding and intends to use the proceeds to launch its service earlier than originally planned to support increased demand from patients and providers across America. Backers included 8vc, Mubadala Capital-Ventures, Montage Ventures, TTCER and Advisors.fund.